spacer
spacer

PDBsum entry 2nxm

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase substrate PDB id
2nxm
Contents
Protein chains
99 a.a.
Ligands
ALA-GLN-THR-PHE-
TYR-VAL-ASP-GLY
Waters ×71

References listed in PDB file
Key reference
Title Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease.
Authors M.D.Altman, E.A.Nalivaika, M.Prabu-Jeyabalan, C.A.Schiffer, B.Tidor.
Ref. Proteins, 2008, 70, 678-694. [DOI no: 10.1002/prot.21514]
PubMed id 17729291
Abstract
Drug resistance in HIV-1 protease, a barrier to effective treatment, is generally caused by mutations in the enzyme that disrupt inhibitor binding but still allow for substrate processing. Structural studies with mutant, inactive enzyme, have provided detailed information regarding how the substrates bind to the protease yet avoid resistance mutations; insights obtained inform the development of next generation therapeutics. Although structures have been obtained of complexes between substrate peptide and inactivated (D25N) protease, thermodynamic studies of peptide binding have been challenging due to low affinity. Peptides that bind tighter to the inactivated protease than the natural substrates would be valuable for thermodynamic studies as well as to explore whether the structural envelope observed for substrate peptides is a function of weak binding. Here, two computational methods-namely, charge optimization and protein design-were applied to identify peptide sequences predicted to have higher binding affinity to the inactivated protease, starting from an RT-RH derived substrate peptide. Of the candidate designed peptides, three were tested for binding with isothermal titration calorimetry, with one, containing a single threonine to valine substitution, measured to have more than a 10-fold improvement over the tightest binding natural substrate. Crystal structures were also obtained for the same three designed peptide complexes; they show good agreement with computational prediction. Thermodynamic studies show that binding is entropically driven, more so for designed affinity enhanced variants than for the starting substrate. Structural studies show strong similarities between natural and tighter-binding designed peptide complexes, which may have implications in understanding the molecular mechanisms of drug resistance in HIV-1 protease.
Figure 1.
Figure 1. Molecular environments of the Glu-P3 (A) and Thr-P2 (B) peptide residues found to be suboptimal for electrostatic binding in the RT-RH crystal complex. The position of the P3 glutamate (A, atom colors, center) is pointed away from Arg8B and makes contact with Phe53A. Calculations suggest an alternative conformation (yellow) that makes better electrostatic interactions with Arg8B at the expense of packing. The wild-type P2 threonine residue (B, center) is situated in a pocket composed of four hydrophobic residues and makes no polar interactions. The crystal structure of a designed mutant peptide with a single threonine-to-valine substitution at the P2 position exhibits a structural rearrangement of the Glu-P3 residue (C, atom colors) as compared to the starting sequence (A). This rearrangement is well supported by calculation (A, C, yellow).
Figure 4.
Figure 4. Superposition of the crystal structures for the RT-RT peptide (green), Peptide 1 (cyan), Peptide 2 (purple), and Peptide 3 (yellow) exhibits structural similarity.
The above figures are reprinted by permission from John Wiley & Sons, Inc.: Proteins (2008, 70, 678-694) copyright 2008.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer